報價延遲最少15分鐘:2025/06/28 13:08 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.76 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.23/-1.24
|
|
企業價值
271.76M
|
| 資產負債 |
|
每股賬面淨值
3.83
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
0.13
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/28 13:08 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotopeLead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties. |